Literature DB >> 11991682

The role of caspase-8 in resistance to cancer chemotherapy.

P K Kim1, R Mahidhara, D W Seol.   

Abstract

Toxicity of chemotherapeutic agents against cancer cells is mediated through the initiation of programmed cell death. Apoptosis is an evolutionarily conserved cascade of intracellular proteolytic events propagated by a family of cysteine proteases called caspases. Many receptor- and non-receptor-mediated death signals induce apoptosis via activation of caspase-8 (FLICE/MACH). Mechanisms of tumor resistance to cytotoxic drugs through decreased apoptosis may occur by altered expression of caspase-8, upregulation of caspase-8 inhibitors like FLIP (FLICE-like Inhibitory Protein), or sequestration of caspase-8 by Bcl-2. Modulation of caspase-8 and apoptosis may be a therapeutic strategy for sensitization of drug-resistant malignancies to radiation or combination chemotherapy. Copyright 2002, Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11991682     DOI: 10.1054/drup.2001.0223

Source DB:  PubMed          Journal:  Drug Resist Updat        ISSN: 1368-7646            Impact factor:   18.500


  14 in total

1.  Phosphorylation of caspase-7 by p21-activated protein kinase (PAK) 2 inhibits chemotherapeutic drug-induced apoptosis of breast cancer cell lines.

Authors:  Xiang Li; Weihong Wen; Kangdong Liu; Feng Zhu; Margarita Malakhova; Cong Peng; Tingting Li; Hong-Gyum Kim; Weiya Ma; Yong Yeon Cho; Ann M Bode; Ziming Dong; Zigang Dong
Journal:  J Biol Chem       Date:  2011-05-09       Impact factor: 5.157

Review 2.  Resistance and gain-of-resistance phenotypes in cancers harboring wild-type p53.

Authors:  Michelle Martinez-Rivera; Zahid H Siddik
Journal:  Biochem Pharmacol       Date:  2011-12-26       Impact factor: 5.858

3.  Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.

Authors:  J N Jeyapalan; D A Mohamed Noor; S-H Lee; C L Tan; V A Appleby; J P Kilday; R D Palmer; E C Schwalbe; S C Clifford; D A Walker; M J Murray; N Coleman; J C Nicholson; P J Scotting
Journal:  Br J Cancer       Date:  2011-06-28       Impact factor: 7.640

4.  Suppression of cFLIP by lupeol, a dietary triterpene, is sufficient to overcome resistance to TRAIL-mediated apoptosis in chemoresistant human pancreatic cancer cells.

Authors:  Imtiyaz Murtaza; Mohammad Saleem; Vaqar Mustafa Adhami; Bilal Bin Hafeez; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

5.  Deregulation of apoptotic factors Bcl-xL and Bax confers apoptotic resistance to myeloid-derived suppressor cells and contributes to their persistence in cancer.

Authors:  Xiaolin Hu; Kankana Bardhan; Amy V Paschall; Dafeng Yang; Jennifer L Waller; Mary Anne Park; Asha Nayak-Kapoor; Thomas A Samuel; Scott I Abrams; Kebin Liu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

6.  Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells.

Authors:  Laura Bergadà; Annabel Sorolla; Andree Yeramian; Nuria Eritja; Cristina Mirantes; Xavier Matias-Guiu; Xavier Dolcet
Journal:  Mol Oncol       Date:  2013-03-28       Impact factor: 6.603

7.  Degradation and dephosphorylation of focal adhesion kinase during okadaic acid-induced apoptosis in human neuroblastoma cells.

Authors:  Bhumsoo Kim; Cynthia M van Golen; Eva L Feldman
Journal:  Neoplasia       Date:  2003 Sep-Oct       Impact factor: 5.715

Review 8.  Cellular FLICE-inhibitory protein: an attractive therapeutic target?

Authors:  Olivier Micheau
Journal:  Expert Opin Ther Targets       Date:  2003-08       Impact factor: 6.902

Review 9.  Potential vascular actions of 2-methoxyestradiol.

Authors:  Raghvendra K Dubey; Edwin K Jackson
Journal:  Trends Endocrinol Metab       Date:  2009-09-04       Impact factor: 12.015

10.  Insulin receptor substrate (IRS)-2, not IRS-1, protects human neuroblastoma cells against apoptosis.

Authors:  Bhumsoo Kim; Eva L Feldman
Journal:  Apoptosis       Date:  2009-05       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.